Valuation: Bayer AG

Capitalization 35.75B 41.46B 32.27B 30.97B 56.47B 3,811B 59.09B 382B 153B 1,827B 156B 152B 6,535B P/E ratio 2026 *
37x
P/E ratio 2027 * 12.5x
Enterprise value 68.14B 79.03B 61.51B 59.02B 108B 7,263B 113B 727B 291B 3,483B 297B 290B 12,456B EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.37x
Free-Float
100%
Yield 2026 *
0.63%
Yield 2027 * 2.37%
1 day-3.67%
1 week-13.38%
Current month-13.38%
1 month-20.55%
3 months+9.26%
6 months+29.25%
Current year-1.68%
1 week 35.38
Extreme 35.38
41.39
1 month 35.38
Extreme 35.38
49.78
Current year 35.38
Extreme 35.38
49.78
1 year 18.38
Extreme 18.378
49.78
3 years 18.38
Extreme 18.378
61.91
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 31/05/2023
Director of Finance/CFO 56 31/05/2018
Chief Tech/Sci/R&D Officer 59 31/01/2021
Director TitleAgeSince
Director/Board Member 69 31/03/2002
Director/Board Member 55 31/03/2012
Director/Board Member 66 31/03/2022
Change 5d. change 1-year change 3-years change Capi.($)
-3.67%-13.38%+56.52%-36.44% 41.46B
+0.72%-5.86%+13.89%+218.81% 885B
+0.32%-3.23%+44.22%+56.01% 579B
-0.96%-0.85%+7.38%+50.47% 407B
-2.93%-7.03%+11.14%+27.55% 350B
-1.25%-5.55%+22.14%+55.83% 302B
-1.85%-6.70%+20.11%+33.64% 301B
-0.24%-6.49%+22.33%+4.06% 286B
+0.53%-4.80%+13.75%+61.56% 199B
-0.83%-3.37%+22.59%+79.29% 179B
Average -1.02%-5.56%+23.41%+55.08% 353.02B
Weighted average by Cap. -0.51%-4.69%+20.70%+87.62%

Financials

2026 *2027 *
Net sales 45.49B 52.76B 41.06B 39.4B 71.85B 4,848B 75.19B 485B 194B 2,325B 198B 194B 8,316B 46.91B 54.41B 42.34B 40.63B 74.09B 5,000B 77.54B 501B 201B 2,398B 204B 200B 8,575B
Net income 1.49B 1.73B 1.34B 1.29B 2.35B 159B 2.46B 15.89B 6.36B 76.1B 6.48B 6.34B 272B 2.96B 3.43B 2.67B 2.56B 4.67B 315B 4.89B 31.54B 12.64B 151B 12.87B 12.59B 540B
Net Debt 32.39B 37.57B 29.24B 28.05B 51.16B 3,452B 53.54B 346B 138B 1,656B 141B 138B 5,921B 28.42B 32.96B 25.65B 24.62B 44.89B 3,029B 46.98B 303B 122B 1,453B 124B 121B 5,195B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,280
Date Price Change Volume
06/03/26 36.39 -3.67% 4,827,217
05/03/26 37.78 +1.00% 5,145,542
04/03/26 37.40 -2.38% 9,110,207
03/03/26 38.31 -5.66% 7,239,455
02/03/26 40.61 -3.33% 3,599,528
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
36.39EUR
Average target price
45.19EUR
Spread / Average Target
+24.18%

Quarterly revenue - Rate of surprise